Back to
HHLR Advisors, Ltd.
AXSM
Showing 0 of 7 quarters
Position history for
HHLR Advisors, Ltd.'s holdings in Axsome Therapeutics, Inc.
No. HHLR Advisors exited its AXSM (Axsome Therapeutics) position in Q4 2023. Its Q3 2023 13F listed 100,000 shares worth $7M. HHLR Advisors first reported AXSM in Q4 2020 and held it in 5 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.